Literature DB >> 15266498

Herbal medicines for viral myocarditis.

J P Liu1, M Yang, X M Du.   

Abstract

BACKGROUND: Herbal medicines are being used for treating viral diseases including viral myocarditis, and many controlled trials have been done to investigate their efficacy.
OBJECTIVES: To assess the effects of herbal medicines on clinical and indirect outcomes in patients with viral myocarditis. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library 2003, Issue 3, MEDLINE (January 1966 to October 2003), EMBASE (January 1998 to October 2003), Chinese Biomedical Database (1979-2003), AMED (1985-2003), LILACS accessed in October 2003 and the trials register of the Cochrane Complementary Medicine Field. We handsearched Chinese journals and conference proceedings. No language or publication restrictions were used. SELECTION CRITERIA: Randomised controlled trials of herbal medicines (with a minimum of seven days treatment duration) compared with placebo, no intervention, or conventional interventions were included. Trials of herbal medicine plus conventional drug versus drug alone were also included. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data and evaluated trial quality. Study authors were contacted for additional information. Adverse effects information was collected from the trials. MAIN
RESULTS: Forty randomised trials, involving 3448 people were included. All trials were conducted and published in China, and the methodological quality was assessed as generally low. No trial had diagnosis of viral myocarditis confirmed histologically, and few trials attempted to establish viral aetiology for the myocarditis. Twenty-five different herbal medicines were tested in the included trials, which compared herbs with supportive therapy (17 trials), other controls (three trials), or treatment of herbs plus supportive therapy with supportive therapy alone (20 trials). The trials reported electrocardiogram, myocardial enzymes, cardiac function, symptoms, and adverse effects. Astragalus membranaceus (either as single herb or compound of herbs) showed significantly effects on improving arrhythmia, CPK levels, and cardiac function. Salviae miltiorrhizae injection showed significant effects on decreasing the arrhythmia and reducing LDH levels. Shenmai and Shengmai injection (Ginseng preparation) showed significantly effects on reducing myocardial enzymes and improving cardiac function. No serious adverse effect was reported. REVIEWERS'
CONCLUSIONS: Some herbal medicines may have anti-arrhythmia effect in suspected viral myocarditis. However, interpretation of these findings should be careful due to the low methodological quality, small sample size, and limited number of trials on individual herbs. In the light of the findings, some herbal medicines deserve further examination in rigorous trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15266498      PMCID: PMC3407372          DOI: 10.1002/14651858.CD003711.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  51 in total

1.  Liver enzyme elevations in patients treated with traditional Chinese medicine.

Authors:  D Melchart; K Linde; W Weidenhammer; S Hager; D Shaw; R Bauer
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

2.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

3.  [A study on combination therapy of Western and traditional Chinese medicine of acute viral myocarditis].

Authors:  W Gu; Y Z Yang; M X He
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1996-12

4.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

Review 5.  Identifying relevant studies for systematic reviews.

Authors:  K Dickersin; R Scherer; C Lefebvre
Journal:  BMJ       Date:  1994-11-12

Review 6.  Idiopathic dilated cardiomyopathy.

Authors:  G W Dec; V Fuster
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

7.  Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.

Authors:  A Staudt; F Schäper; V Stangl; A Plagemann; M Böhm; K Merkel; G Wallukat; K D Wernecke; K Stangl; G Baumann; S B Felix
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

8.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  BMJ       Date:  2010-03-23

Review 9.  Herbal medicine for dementia: a systematic review.

Authors:  Brian H May; M Lit; Charlie C L Xue; Angela W H Yang; Anthony L Zhang; Michael D Owens; Richard Head; Lynne Cobiac; Chun Guang Li; Helmut Hugel; David F Story
Journal:  Phytother Res       Date:  2009-04       Impact factor: 5.878

10.  Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression.

Authors:  P A Vignola; K Aonuma; P S Swaye; J J Rozanski; R L Blankstein; J Benson; A J Gosselin; J W Lister
Journal:  J Am Coll Cardiol       Date:  1984-10       Impact factor: 24.094

View more
  8 in total

Review 1.  Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapies.

Authors:  Eric Manheimer; Susan Wieland; Elizabeth Kimbrough; Ker Cheng; Brian M Berman
Journal:  J Altern Complement Med       Date:  2009-09       Impact factor: 2.579

2.  Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4.

Authors:  Juan Xie; Huan Wang; Tiebing Song; Zongren Wang; Feng Li; Jing Ma; Jun Chen; Yayun Nan; Hui Yi; Wen Wang
Journal:  Protoplasma       Date:  2012-08-08       Impact factor: 3.356

Review 3.  Chinese herbal medicines for hypercholesterolemia.

Authors:  Zhao Lan Liu; Jian Ping Liu; Anthony Lin Zhang; Qiong Wu; Yao Ruan; George Lewith; Denise Visconte
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 4.  A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity.

Authors:  Shirin Hasani-Ranjbar; Neda Nayebi; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

5.  Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals.

Authors:  Karen L Denzler; Robert Waters; Bertram L Jacobs; Yvan Rochon; Jeffrey O Langland
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

6.  Reliability and External Validity of AMSTAR in Assessing Quality of TCM Systematic Reviews.

Authors:  Deying Kang; Yuxia Wu; Dan Hu; Qi Hong; Jialiang Wang; Xin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-16       Impact factor: 2.629

Review 7.  Cochrane systematic reviews of Chinese herbal medicines: an overview.

Authors:  Jing Hu; Junhua Zhang; Wei Zhao; Yongling Zhang; Li Zhang; Hongcai Shang
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

8.  Ethnoveterinary medicines used for horses in Trinidad and in British Columbia, Canada.

Authors:  Cheryl Lans; Nancy Turner; Gerhard Brauer; Grant Lourenco; Karla Georges
Journal:  J Ethnobiol Ethnomed       Date:  2006-08-07       Impact factor: 2.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.